Home
iNGENū CRO

iNGENū CRO Market Share Analysis for May 2026

Leading clinical research organization delivering high-quality, FDA-compliant research for innovative biotech firms. Australian expertise, global reach.

Industry: N/A

Domainingenucro.com

Year Founded2018

Employees51 - 200

Annual Revenue--

iNGENū CRO

iNGENū CRO (including company regionals)

ingenucro.com

See more website traffic and engagement information

Total visits to iNGENū CRO's top domains

Understand iNGENū CRO market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ingenucro.com435

See more with Sales Intelligence

Avg. visit duration in iNGENū CRO's top domains

Analyze iNGENū CRO engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ingenucro.com--

See more with Sales Intelligence

Avg. pageviews on iNGENū CRO's top domains

See how iNGENū CRO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ingenucro.com1.09

See more with Sales Intelligence

iNGENū CRO top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by iNGENū CRO

These are the website technologies, by industry, used by iNGENū CRO top domains

Payment & Currencies (8)

Cart Functionality

Widget (5)

Twemoji

Advertising (4)

PubMatic

Conversion & Analytics (3)

Google Analytics

More Technologies

10

See all

News & Signals from iNGENū CRO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPsyence Biomed partners with Ingenu CRO.Psyence Biomed partners with Fluence and iNGENū CRO to train research therapists for Phase IIb psilocybin trial.

NewsFSD Pharma Inc partners with Ingenu CRO.FSD Pharma Inc. has partnered with Ingenu CRO to conduct a clinical trial on their proprietary beverage, unbuzzd(TM), aiming to prove its safety and effectiveness in hastening sobriety following alcohol consumption.

NewsQuantum BioPharma Ltd. partners with Ingenu CRO.Quantum Biopharma signs an agreement with Ingenu CRO to conduct a clinical study to observe disease progression in patients with primary progressive multiple sclerosis.